Before analyzing a company for investment, it’s important to have a perspective on how well the business has performed. Because at the end of the day, if you are an investor, you are buying the business. The FAST Graphs™ presented with this article will focus first on the business behind the stock. The orange line on the graph plots earnings per share since 2003. A quick glance vividly reveals the historical operating record of...
Read More »
Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR) is expected to deliver strong revenue and earnings growth for several years, according to analysts at Cannacord Genuity, due to the increasing penetration of its Keurig coffee makers among households in North America. Cannacord Genuity analysts, Scott Van Winkle and Mark Sigal noted that Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR)’s second quarter financial performance is 25 percent higher than their expectations as well as consensus EPS estimates on...
Read More »
Introduction We believe there are two critical attributes that the prudent investor should consider before investing in a company (stock). Furthermore, these same two attributes can be used to calculate a reasonable expectation of the future return the stock is capable of generating on their behalf. These two attributes are valuation and the rate of change of earnings growth. Valuation indicates whether or not the company’s current earnings power compensates you for the risk...
Read More »
Introduction In parts one and two of this three-part series I presented a case that focused on the long-term potential for a bright future of economic strength and growth. Moreover, I pointed out that I felt that the best of what our economic future holds goes mostly ignored, in favor of a focus on our problems. Therefore, I concluded that there exists a general pessimistic view of our future that I believe is wrong. In the long run,...
Read More »
With baby boomers being one of the biggest population bubbles, medical suppliers can be a healthy addition to a portfolio. Here are five medical supply companies that are trading below their normal historical PE ratios and inline or slightly below their estimated growth rates. Consequently, they represent an opportunity for above-average growth and yield. Five Medical Suppliers Portfolio Review The following table summarizes five medical suppliers that appear to be attractively valued, and lists...
Read More »
….This report presented essential “fundamentals at a glance” illustrating the past and present valuation based on earnings achievements as reported. Future forecasts for earnings growth are based on the consensus of leading analysts. Although, with just a quick glance you can know a lot about the company, it’s imperative that the reader conducts their own due diligence in order to validate whether the consensus estimates seem reasonable or not. ResMed (RMD) represents a classic...
Read More »
